CRDF icon

Cardiff Oncology
CRDF

Overview Fund Trends Analyst Outlook Journalist POV

38 hedge funds and large institutions have $797K invested in Cardiff Oncology in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

89% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 9

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$1K
Net Calls
Net Calls Change

Top Buyers

1
+$17.6K
2
+$4.83K
3
+$1.04K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$628
5
Northern Trust
Northern Trust
Illinois
+$531

Top Sellers

1
-$1.23M
2
-$357K
3
-$116K
4
Millennium Management
Millennium Management
New York
-$70.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2K
27
$1K
28
$1K
29
$1K
30
$1K
31
$1K
32
$1K
33
$6
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
1
2